Please use this identifier to cite or link to this item:
|Statistics||SHARE CORE MendeleyBASE||
|Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL|
Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?
|Authors:||González-Rey, Elena; Delgado, M.|
|Citation:||Trends in Pharmacological Sciences 28: 482- 491 (2007)|
|Abstract:||The loss of immune tolerance results in the breakdown of immune homeostasis and the appearance of exacerbated inflammatory conditions. Some anti-inflammatory neuropeptides have recently emerged as endogenous factors participating in the maintenance of immune tolerance. The effects of these neuropeptides in self-tolerance primarily depend on the activation of cAMP-protein kinase A signaling and the regulation of various transduction pathways involved in the expression of many immune factors. Understanding of the structure-function relationship of anti-inflammatory neuropeptides and their receptors will facilitate the development of novel pharmacological agents for the treatment of immune disorders. © 2007 Elsevier Ltd. All rights reserved.|
|Appears in Collections:||(IPBLN) Artículos|